Search | Search by Center | Search by Source | Keywords in Title
Compher C, Levinson KB, Cambor CL, Stoner N, Boullata JI, Piarulli A, Kinosian B. A Patient With Parenteral Nutrition-Dependent Short Bowel Syndrome and Cardiovascular Disease With 4-Year Exposure to Teduglutide. Jpen. Journal of Parenteral and Enteral Nutrition. 2016 Jul 1; 40(5):725-9.
Clinical trials of the glucagon-like peptide 2 analogue teduglutide resulted in approval of the drug by the Food and Drug Administration in 2012 as a treatment for parenteral nutrition-dependent short bowel syndrome in adults. This report presents the case study of a man with short bowel syndrome caused by portal vein thrombosis who had 4 years exposure to the drug at the time of his death due to cardiovascular disease.